FSHR p.Ser680Asn

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -14 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_ModerateBP6_Strong

The NM_000145.4(FSHR):c.2039G>A (p.Ser680Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.558 (AC=900,176) in the gnomAD database across 1,613,272 control chromosomes, including 252,236 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.661. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.57 ( 24652 hom., cov: 32)
Exomes 𝑓: 0.56 ( 227584 hom. )

Consequence

FSHR
NM_000145.4 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.0530

Publications

379 publications found
Variant links:
Genes affected
FSHR (HGNC:3969): (follicle stimulating hormone receptor) The protein encoded by this gene belongs to family 1 of G-protein coupled receptors. It is the receptor for follicle stimulating hormone and functions in gonad development. Mutations in this gene cause ovarian dysgenesis type 1, and also ovarian hyperstimulation syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
FSHR Gene-Disease associations (from GenCC):
  • ovarian hyperstimulation syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
  • ovarian dysgenesis 1
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • 46 XX gonadal dysgenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000145.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -14 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Moderate).
BP6
ClinVar 2-star benign — strong (BP6); ClinVar germline classification: Benign/Likely Benign, 2 star(s).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.6607 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000145.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FSHR
NM_000145.4
MANE Select
c.2039G>Ap.Ser680Asn
missense
Exon 10 of 10NP_000136.2
FSHR
NM_181446.3
c.1961G>Ap.Ser654Asn
missense
Exon 9 of 9NP_852111.2P23945-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FSHR
ENST00000406846.7
TSL:1 MANE Select
c.2039G>Ap.Ser680Asn
missense
Exon 10 of 10ENSP00000384708.2P23945-1
FSHR
ENST00000304421.8
TSL:1
c.1961G>Ap.Ser654Asn
missense
Exon 9 of 9ENSP00000306780.4P23945-3
MIR548BAHG
ENST00000634588.1
TSL:5
n.492+16377C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.568
AC:
86242
AN:
151908
Hom.:
24645
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.583
Gnomad AMI
AF:
0.515
Gnomad AMR
AF:
0.602
Gnomad ASJ
AF:
0.481
Gnomad EAS
AF:
0.680
Gnomad SAS
AF:
0.562
Gnomad FIN
AF:
0.552
Gnomad MID
AF:
0.481
Gnomad NFE
AF:
0.551
Gnomad OTH
AF:
0.556
GnomAD2 exomes
AF:
0.574
AC:
144230
AN:
251060
AF XY:
0.569
show subpopulations
Gnomad AFR exome
AF:
0.592
Gnomad AMR exome
AF:
0.671
Gnomad ASJ exome
AF:
0.476
Gnomad EAS exome
AF:
0.669
Gnomad FIN exome
AF:
0.556
Gnomad NFE exome
AF:
0.548
Gnomad OTH exome
AF:
0.566
GnomAD4 exome
AF:
0.557
AC:
813884
AN:
1461246
Hom.:
227584
Cov.:
48
AF XY:
0.555
AC XY:
403744
AN XY:
726958
show subpopulations
African (AFR)
AF:
0.589
AC:
19699
AN:
33468
American (AMR)
AF:
0.659
AC:
29452
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.471
AC:
12314
AN:
26134
East Asian (EAS)
AF:
0.656
AC:
26024
AN:
39688
South Asian (SAS)
AF:
0.542
AC:
46739
AN:
86254
European-Finnish (FIN)
AF:
0.555
AC:
29661
AN:
53418
Middle Eastern (MID)
AF:
0.510
AC:
2939
AN:
5764
European-Non Finnish (NFE)
AF:
0.552
AC:
613307
AN:
1111428
Other (OTH)
AF:
0.559
AC:
33749
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
19909
39818
59727
79636
99545
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17324
34648
51972
69296
86620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.568
AC:
86292
AN:
152026
Hom.:
24652
Cov.:
32
AF XY:
0.567
AC XY:
42132
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.583
AC:
24186
AN:
41456
American (AMR)
AF:
0.602
AC:
9197
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.481
AC:
1668
AN:
3466
East Asian (EAS)
AF:
0.679
AC:
3514
AN:
5172
South Asian (SAS)
AF:
0.561
AC:
2701
AN:
4818
European-Finnish (FIN)
AF:
0.552
AC:
5828
AN:
10552
Middle Eastern (MID)
AF:
0.490
AC:
144
AN:
294
European-Non Finnish (NFE)
AF:
0.550
AC:
37415
AN:
67966
Other (OTH)
AF:
0.554
AC:
1169
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1928
3857
5785
7714
9642
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
740
1480
2220
2960
3700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.556
Hom.:
108435
Bravo
AF:
0.574
Asia WGS
AF:
0.588
AC:
2045
AN:
3478
EpiCase
AF:
0.540
EpiControl
AF:
0.543

Local populations

ToMMo 61KJPN (+60KJPN MNV)
AF:
0.651
AC:
79969
AN:
122806
Turkish Variome
AF:
0.502
AC:
3372
AN:
6722
Hom.:
866
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.682
AC:
6110
AN:
8960
Hom.:
2082
ABraOM SABE-WGS-1171
AF:
0.577
AC:
1352
AN:
2342
Hom.:
396

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Ovarian hyperstimulation syndrome (3)
-
-
2
not provided (2)
-
-
2
Ovarian dysgenesis 1 (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
0.29
DANN
Benign
0.18
Eigen
Benign
-0.88
Eigen_PC
Benign
-0.86
FATHMM_MKL
Benign
0.0068
N
LIST_S2
Benign
0.11
T
MetaRNN
Benign
0.0000060
T
MetaSVM
Benign
-0.92
T
PhyloP100
0.053
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.38
N
REVEL
Benign
0.033
Sift
Benign
0.97
T
Sift4G
Benign
0.71
T
gMVP
0.30
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs6166;
hg19: chr2-49189921;
COSMIC: COSV58619885;
COSMIC: COSV58619885;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.